Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells

被引:432
作者
Ghosh, J [1 ]
Myers, CE [1 ]
机构
[1] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA
关键词
D O I
10.1073/pnas.95.22.13182
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Diets high in fat are associated with an increased risk of prostate cancer, although the molecular mechanism is still unknown, We have previously reported that arachidonic acid, an omega-6 fatty acid common in the Western diet, stimulates proliferation of prostate cancer cells through production of the 5-lipoxygenase metabolite, 5-HETE (5-hydroxyeicosatetraenoic acid). We now show that 5-HETE is also a potent survival factor for human prostate cancer cells. These cells constitutively produce 5-HETE in serum-free medium with no added stimulus. Exogenous arachidonate markedly increases the production of 5-HETE, Inhibition of 5-lipoxygenase by MK886 completely blocks 5-HETE production and induces massive apoptosis in both hormone-responsive (LNCaP) and -nonresponsive (PC3) human prostate cancer cells. This cell death is very rapid: cells treated with MKS86 showed mitochondrial permeability transition between 30 and 60 min, externalization of phosphatidylserine within 2 hr, and degradation of DNA to nucleosomal subunits beginning within 2-4 hr posttreatment, Cell death was effectively blocked by the thiol antioxidant, N-acetyl-L-cysteine, but not by androgen, a powerful survival factor for prostate cancer cells. Apoptosis was specific for 5-lipoxygenase-programmed cell death was not observed with inhibitors of 12-lipoxygenase, cyclooxygenase, or cytochrome P450 pathways of arachidonic acid metabolism, Exogenous 5-HETE protects these cells from apoptosis induced by 5-lipoxygenase inhibitors, confirming a critical role of 5-lipoxygenase activity in the survival of these cells. These findings provide a possible molecular mechanism by which dietary fat may influence the progression of prostate cancer.
引用
收藏
页码:13182 / 13187
页数:6
相关论文
共 45 条
[1]   RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL OF A SELECTIVE 5-LIPOXYGENASE INHIBITOR (AA-861) FOR THE PREVENTION OF SEASONAL ALLERGIC RHINITIS [J].
ANCILL, RJ ;
TAKAHASHI, Y ;
KIBUNE, Y ;
CAMPBELL, R ;
SMITH, JR .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1990, 18 (02) :75-88
[2]   Cyclooxygenase and lipoxygenase inhibitors in cancer therapy [J].
Ara, G ;
Teicher, BA .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1996, 54 (01) :3-16
[3]  
BERCHEM GJ, 1995, CANCER RES, V55, P735
[4]   CHEMOPREVENTION OF PROSTATE-CANCER [J].
BRAWLEY, OW ;
THOMPSON, IM .
UROLOGY, 1994, 43 (05) :594-599
[5]   PHARMACOLOGY OF MK-0591 (3-[1-(4-CHLOROBENZYL)-3-(T-BUTYLTHIO)-5-(QUINOLIN-2-YL-METHOXY)-INDOL-2-YL]-2,2-DIMETHYL PROPANOIC ACID), A POTENT, ORALLY ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITOR [J].
BRIDEAU, C ;
CHAN, C ;
CHARLESON, S ;
DENIS, D ;
EVANS, JF ;
FORDHUTCHINSON, AW ;
FORTIN, R ;
GILLARD, JW ;
GUAY, J ;
GUEVREMONT, D ;
HUTCHINSON, JH ;
JONES, TR ;
LEGER, S ;
MANCINI, JA ;
MCFARLANE, CS ;
PICKETT, C ;
PIECHUTA, H ;
PRASIT, P ;
RIENDEAU, D ;
ROUZER, CA ;
TAGARI, P ;
VICKERS, PJ ;
YOUNG, RN ;
ABRAHAM, WM .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (06) :799-807
[6]   OXIDATIVE STRESS AS A MEDIATOR OF APOPTOSIS [J].
BUTTKE, TM ;
SANDSTROM, PA .
IMMUNOLOGY TODAY, 1994, 15 (01) :7-10
[7]   Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses [J].
Byrum, RS ;
Goulet, JL ;
Griffiths, RJ ;
Koller, BH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (06) :1065-1075
[8]   ARACHIDONIC-ACID METABOLISM IN BENIGN AND MALIGNANT PROSTATIC TISSUE IN-VITRO - EFFECTS OF FATTY-ACIDS AND CYCLOOXYGENASE INHIBITORS [J].
CHAUDRY, AA ;
WAHLE, KWJ ;
MCCLINTON, S ;
MOFFAT, LEF .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (02) :176-180
[9]   ROLE OF LEUKOTRIENES REVEALED BY TARGETED DISRUPTION OF THE 5-LIPOXYGENASE GENE [J].
CHEN, XS ;
SHELLER, JR ;
JOHNSON, EN ;
FUNK, CD .
NATURE, 1994, 372 (6502) :179-182
[10]   A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA [J].
CRAWFORD, ED ;
EISENBERGER, MA ;
MCLEOD, DG ;
SPAULDING, JT ;
BENSON, R ;
DORR, FA ;
BLUMENSTEIN, BA ;
DAVIS, MA ;
GOODMAN, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (07) :419-424